A Study to Explore the Effect of Acid-reducing Agents
Status:
Active, not recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
A Phase 1 Study of the Effect of Acid-reducing Agents on the Pharmacokinetics of a Single
Oral Dose of Sitravatinib in Healthy Adult Subjects. The study is a single-center,
open-label, 2-period, 2-treatment, fixed-sequence crossover, parallel-group study.